78% Of Diabetics Want It – The Latest From Novo Nordisk


By: dhtest

Novo Nordisk recently introduced Novolin Prefilled, a self-contained insulin delivery system, in two additional human insulin forms-Regular (short acting) and NPH (intermediate acting).

Novolin Prefilled is a multi-use, disposable insulin syringe filled with 150 units of Novolin human insulin (recombinant DNA origin). It features a dial-a-dose system that makes the insulin preparation stage of insulin injection easier, and it is used with NovoFine 30, which Novo Nordisk calls the “shortest, finest needle available in the United States.”

In a recent survey, people with diabetes who had never taken insulin viewed video clips of a person using a traditional syringe and vial and of a person demonstrating Novolin Prefilled. Seventy-eight percent of those surveyed expressed a preference for the new Novo Nordisk product.

Says Ken Capuano, president of Novo Nordisk Pharmaceuticals, “We believe that by offering patients with diabetes more products that help simplify their therapy we can enhance compliance with the most effective therapeutic regimens.”



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.